The monthly cost of Tymlos (abaloparatide) can vary significantly depending on insurance coverage, pharmacy, and whether any patient assistance programs are applied. Without insurance, the list price for a one-month supply of Tymlos can range from approximately $9,000 to over $10,000 [1].
How much does Tymlos cost with insurance?
Insurance plans often reduce the out-of-pocket cost for Tymlos. Many plans have copay programs or deductibles that influence the final price. Patients may pay a percentage of the drug's cost or a fixed copay amount, which can range from $0 to several hundred dollars per month, depending on the specific insurance policy [2].
Are there patient assistance programs for Tymlos?
Yes, patient assistance programs are available to help reduce the cost of Tymlos for eligible individuals. These programs can include copay cards that lower out-of-pocket expenses for insured patients, as well as options for uninsured or underinsured individuals who meet certain financial criteria [2]. For instance, eligible commercially insured patients may pay as little as $0 per monthly prescription through a savings program [3].
What is the wholesale acquisition cost of Tymlos?
The wholesale acquisition cost (WAC) for Tymlos is a benchmark price that does not reflect what patients actually pay. It is the price pharmaceutical manufacturers set for their drugs before discounts, rebates, and other price reductions negotiated between manufacturers, wholesalers, and pharmacies [1].
How does Tymlos pricing compare to other osteoporosis treatments?
Tymlos is a high-cost medication, which is common for biologic and injectable treatments for osteoporosis. Other injectable medications, such as Forteo (teriparatide), also carry significant monthly costs that can run into thousands of dollars before insurance or assistance programs are applied. Oral medications for osteoporosis are generally less expensive but may not be as effective for all patients or may have different administration schedules [4].
When does the patent for Tymlos expire?
The patent landscape for Tymlos is complex and may involve multiple patents covering the drug itself, its methods of use, and manufacturing processes. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on patent expiry dates and potential challenges that could affect market exclusivity [5]. Generally, the expiration of key patents opens the door for generic or biosimilar competition, which could potentially lower costs in the future.